The Hindu Business Line : Elder Pharma ties up with Cymbiotics

Mumbai May 29 Elder Pharmaceuticals has forged an in-licensing agreement with US-based bio-pharmaceutical company Cymbiotics in the pain management and diabetes segments, among others.

The Mumbai-based company will sell Pedicur, a cream for dry feet and elbows that usually occur in cases of chronic diabetes; Diaperin, a cream for neuropathic pain and Lepislim, an oral prescription that helps reduce weight. The deal strengthens Elder's presence in pain management, diabetes and derma care.

Cymbiotics' President and Chief Executive Officer, Dr Raj Barathur, said that the company already sells the same formulation contained in Pedicur, but under a different brand name (Celadrin) with Dr Reddy's Laboratories Ltd. A similar agreement for the same product is in place with Cipla too, he added. The company has tied up with different companies for better distribution in different markets, he said.

No financial details on the size of the products or the revenue sharing between the different companies were divulged.

Phase III b trials

The company has sought regulatory approvals from the Drug Controller General of India to conduct phase III b trials on Lepislim, he said. The trialwill be done through a contract research organisation, he said.

Cymbiotics is also in the process of shifting about 70 per cent of its San Diego-based research to Hyderabad, he said. This would be operational next month.

More Stories on : Alliances & Joint Ventures | Pharmaceuticals | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
`IOC losing Rs 2,500 cr every month'

50% rise in L&T fourth quarter net profit

HPCL Q4 net drops 73% at Rs 549.5 crore

Nagarjuna Construction Q4 net rises 40%

BMW to source components from India

Ranbaxy allowed to launch generic Lipitor

Scotland still lukewarm to Mallya

Strides enters fermentation biz; buys Italian company's unit

DS Constructions set to buy Globeleq unit

Aurobindo drug gets US FDA nod

Tata Steel signs MoU with Vietnam company

Elder Pharma ties up with Cymbiotics

`Scope for more joint ventures with Australia'

Hind Shipyard revamp for GoM

Eli Lilly working on diabetes injectible drug